Home » Drug Information » FDA-Approved Drugs » 2000
Medical Areas: Immunology/Infectious Diseases | Obstetrics/Gynecology
View By: Year Company Therapeutic Areas Drug Names
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Taro Pharmaceuticals
Approval Status: Approved April 2000
Treatment Area: For the treatment of vaginal yeast infections
Trivagizole 3 is a three-day over-the-counter topical cream
approved for the treatment of vaginal yeast infections. (Its active
ingredient, clotrimazole, is also indicated for the treatment of
jock itch, athlete's foot, thrush infections of the esophagus
and mouth and candida of the scrotum and anus.)
Few to no side effects are experienced with topical treatment.
However, sexual partners may experience minor skin irritation due
to exposure to the medication. To prevent this, refrain from sex
during treatment or have male partners use condoms.
Other instructions:
- Change clothing in contact with the infected area after each
application
- Use the preparation at bedtime for maximum contact with mucous
membranes
- Lie down for at least 30 minutes following treatment
- Use sanitary napkins to prevent staining of clothing or
bedding
If you miss a dose, do not take a double dose
to compensate.
This drug may be compared to Gyne-Lotrimin, Lotrimin, or
Mycelex.
Visit the Taro
Pharmaceuticals, Inc. web site to learn more about Trivagizole
3 and about other products, research, and services provided by the
company that developed this drug.
